CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2019	Mar. 31, 2019
Current assets
Cash	$ 785,658	$ 3,828,074
Prepaid expenses and other current assets	114,036	210,042
Total current assets	899,694	4,038,116
Property and equipment, net	124,833	6,021
Right-of-use lease asset	183,018	0
Patents, net	62,086	66,668
Deposits	12,159	12,159
Total assets	1,281,790	4,122,964
Current liabilities
Accounts payable	586,960	131,931
Due to related parties	101,462	83,654
Convertible notes payable, net	0	962,301
Deferred revenue	100,000	0
Lease liability, current portion	94,885	0
Other current liabilities	285,211	646,000
Total current liabilities	1,168,518	1,823,886
Lease liability, less current portion	92,600	0
Total liabilities	1,261,118	1,823,886
Commitments and Contingencies (Note 13)
Stockholders' Equity
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 1,337,259 and 1,266,979 shares issued and outstanding as of September 30, 2019 and March 31, 2019, respectively	1,338	1,267
Additional paid-in capital	109,571,708	108,076,275
Accumulated deficit	(109,423,894)	(105,652,433)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests	149,152	2,425,109
Noncontrolling interests	(128,480)	(126,031)
Total stockholders' equity	20,672	2,299,078
Total liabilities and stockholders' equity	$ 1,281,790	$ 4,122,964

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.